Details for New Drug Application (NDA): 020555
✉ Email this page to a colleague
The generic ingredient in AXID AR is nizatidine. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Summary for 020555
Tradename: | AXID AR |
Applicant: | Haleon Us Holdings |
Ingredient: | nizatidine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020555
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
Approval Date: | May 9, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020555
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription